Signaturefd, LLC Morpho Sys Ag Transaction History

Signaturefd, LLC

$4.72 Billion
Q1 2024

A detailed history of Signaturefd, LLC transactions in Morpho Sys Ag stock. As of the latest transaction made, Signaturefd, LLC holds 2,968 shares of MOR stock, worth $53,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,968

Previous 2,628 12.94%

Holding current value

$53,720

Previous $26,000 103.85%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$8.6 - $18.18 $2,924 - $6,181	340 Added 12.94%	2,968 $53,000
Q4 2023 Jan 31, 2024	SELL	$4.55 - $9.9 $273 - $594	-60 Reduced 2.23%	2,628 $26,000
Q3 2023 Nov 03, 2023	BUY	$6.72 - $8.6 $1,827 - $2,339	272 Added 11.26%	2,688 $18,000
Q2 2023 Aug 01, 2023	BUY	$3.95 - $7.74 $8,942 - $17,523	2,264 Added 1489.47%	2,416 $18,000
Q1 2023 Apr 28, 2023	SELL	$3.56 - $5.22 $2,605 - $3,821	-732 Reduced 82.81%	152 $0

Q4 2022 Jan 27, 2023	SELL	$3.21 - $5.74 $3,826 - $6,842	-1,192 Reduced 57.42%	884 $3,000
Q3 2022 Nov 08, 2022	SELL	$4.14 - $22.13 $11,095 - $59,308	-2,680 Reduced 56.35%	2,076 $10,000
Q2 2022 Aug 10, 2022	SELL	$4.51 - $7.39 $4,455 - $7,301	-988 Reduced 17.2%	4,756 $23,000
Q1 2022 May 02, 2022	SELL	$5.87 - $9.73 $21,578 - $35,767	-3,676 Reduced 39.02%	5,744 $39,000
Q4 2021 Jan 25, 2022	BUY	$9.08 - $12.45 $46,380 - $63,594	5,108 Added 118.46%	9,420 $89,000
Q3 2021 Oct 28, 2021	BUY	$11.76 - $19.51 $43,464 - $72,108	3,696 Added 600.0%	4,312 $51,000
Q2 2021 Jul 26, 2021	BUY	$18.95 - $23.95 $11,673 - $14,753	616 New	616 $12,000
Q1 2021 Apr 30, 2021	SELL	$21.56 - $30.66 $1,207 - $1,716	-56 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$24.81 - $30.33 $1,389 - $1,698	56 New	56 $2,000
Q3 2020 Nov 03, 2020	SELL	$30.28 - $35.72 $3,754 - $4,429	-124 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$18.86 - $37.36 $2,338 - $4,632	124 New	124 $3,000

Others Institutions Holding MOR

# of Institutions

Shares Held

11.3M

Call Options Held

320K

Put Options Held

1.1M

View Full List

About MorphoSys AG

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Market Cap $2.47B
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

More about MOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account